Skip to content

Clinical trials

Observational Squamous Cell Carcinoma of Head and Neck trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Observational Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20042
20054
20064
20075
20084
20092
20104
20123
20131
20141
20151
20161
20172
20193
20206
20212
20222
20232
20243
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting11
Terminated5
Active, not recruiting5
Unknown status5
Withdrawn3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vanderbilt-Ingram Cancer Center7
Vanderbilt University Medical Center5
M.D. Anderson Cancer Center3
Vanderbilt University3
Bristol-Myers Squibb2
Massachusetts Eye and Ear Infirmary2
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
University of California, San Francisco2
Viome2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck62
Head and Neck Neoplasms32
Salivary Gland Neoplasms16
Carcinoma, Non-Small-Cell Lung10
Esthesioneuroblastoma, Olfactory8
Colorectal Neoplasms6
Breast Neoplasms5
Carcinoma, Squamous Cell5
Lung Neoplasms5
Mouth Neoplasms5

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.